EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study

Yuanzhi Gong, Yuhao Liu, Yunlou Zhu, Shikui Mu, Hanlu Gao, Xin Jing, Yingying Du iD, Sheng Wang iD

Microbiology Spectrum · 2025-07 · 13 (7)

DOI: 10.1128/spectrum.02564-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025-07. Verfasst von Yuanzhi Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Bacterial Agents, Tetracyclines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cinical Research Project of the Shanghai Municipal Health Commission, Shanghai Hospital Development Center Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eravacycline, a novel tetracycline antibiotic, may be an effective treatment option for Klebsiella pneumoniae infections. We thus conducted an in vitro susceptibility analysis for eravacycline in 211 K. pneumoniae isolates. Eravacycline achieved an overall susceptibility rate of 86% against K. pneumoniae , and the sensitivity rates to carbapenem-susceptible Klebsiella pneumoniae and carbapenem-resistant Klebsiella pneumoniae (CRKP) strains were 100% and 84%, respectively. The combined drug sensitivity test in vitro for eravacycline and polymyxin B demonstrated a synergistic effect in 20% of eravacycline-resistant CRKP strains. IMPORTANCE Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a global priority pathogen due to its limited therapeutic options and high morbidity, which urgently needs new antibiotics that are not affected by common resistance mechanisms. As the next generation of fluorocycline antibiotics, eravacycline can circumvent the tetracycline-specific resistance pathways by its structural modifications, which may be a candidate antibiotic for CRKP infections. The present study evaluated the in vitro activity of eravacycline against CRKP strains, including carbapenemase producers, and explored synergistic interactions with existing antibiotics. By determining the efficacy spectrum and combinatorial potential for eravacycline, this study will directly guide clinical strategies to combat infections caused by CRKP and optimize treatment regimens for high-risk populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAnti-Bacterial AgentsTetracyclinesMicrobial Sensitivity TestsHumansKlebsiella InfectionsDrug SynergismPolymyxin BDrug Resistance, Multiple, BacterialBacterial Proteins

Stichwörter der Autor:innen

Klebsiella pneumoniaeantibiotic combination treatmenteravacyclinepolymyxin B

Substanzen

Anti-Bacterial AgentsTetracyclineseravacyclinePolymyxin BBacterial Proteins

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Intensive Care Medical Centre, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Yingying Du, Sheng Wang

Förderung

  • Cinical Research Project of the Shanghai Municipal Health Commission
  • Shanghai Hospital Development Center Foundation

Zitieren

APA

Gong, Y., Liu, Y., Zhu, Y., Mu, S., Gao, H., Jing, X., Du, Y., & Wang, S. (2025). Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study. Microbiology Spectrum, 13(7). https://doi.org/10.1128/spectrum.02564-24

Vancouver

Gong Y, Liu Y, Zhu Y, Mu S, Gao H, Jing X, et al. Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study. Microbiology Spectrum. 2025;13(7). doi:10.1128/spectrum.02564-24

BibTeX
@article{Gong2025,
  author = {Gong, Yuanzhi and Liu, Yuhao and Zhu, Yunlou and Mu, Shikui and Gao, Hanlu and Jing, Xin and Du, Yingying and Wang, Sheng},
  title = {Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {7},
  doi = {10.1128/spectrum.02564-24}
}
Kostenlos starten →